Showing results (251-260 of 355) with videos related to

Sort By:
Pageof 36
JACC. Heart Failure|December 6, 2025
Finerenone and Cardiovascular Outcomes According to Baseline Kidney Function in Patients With Heart Failure: The FINEARTS-HF TrialFinnian R Mc Causland, Safia Chatur, Muthiah Vaduganathan, et al.
European Journal of Heart Failure|May 16, 2025
Anaemia in patients with heart failure and mildly reduced or preserved ejection fraction: A prespecified analysis of the FINEARTS-HF trialMisato Chimura, Mingming Yang, Alasdair D Henderson, et al.
Diabetes, Obesity & Metabolism|April 8, 2024
Effects of high-dose versus standard-dose quadrivalent influenza vaccine among patients with diabetes: A post-hoc analysis of the DANFLU-1 trialMats C Højbjerg Lassen, Niklas Dyrby Johansen, Daniel Modin, et al.
JACC. Heart Failure|September 28, 2023
Contemporary Use and Implications of Beta-Blockers in Patients With HFmrEF or HFpEF: The DELIVER TrialAlexander Peikert, Bradley A Bart, Muthiah Vaduganathan, et al.
European Journal of Heart Failure|September 2, 2022
Dapagliflozin and New York Heart Association functional class in heart failure with mildly reduced or preserved ejection fraction: the DELIVER trialJohn W Ostrominski, Muthiah Vaduganathan, Brian L Claggett, et al.
Journal of the American College of Cardiology|May 20, 2021
Effect of Ejection Fraction on Clinical Outcomes in Patients Treated With Omecamtiv Mecarbil in GALACTIC-HFJohn R Teerlink, Rafael Diaz, G Michael Felker, et al.
ESC Heart Failure|February 19, 2026
Efficacy of aficamten according to geographic location of patients with hypertrophic obstructive cardiomyopathyCaroline J Coats, Theodore Abraham, Roberto Barriales-Villa, et al.
JAMA Cardiology|February 22, 2023
Association of Dapagliflozin Use With Clinical Outcomes and the Introduction of Uric Acid-Lowering Therapy and Colchicine in Patients With Heart Failure With and Without Gout: A Patient-Level Pooled Meta-analysis of DAPA-HF and DELIVERJawad H Butt, Kieran F Docherty, Brian L Claggett, et al.
The Journal of Infectious Diseases|August 12, 2025
Relative effectiveness of high-dose versus standard-dose influenza vaccine against hospitalizations and mortality according to frailty score: A post-hoc analysis of the DANFLU-1 randomized trialCaroline Espersen, Niklas Dyrby Johansen, Daniel Modin, et al.
American Heart Journal|June 20, 2025
Electronically delivered, cardiovascular-focused messaging to improve influenza vaccination: Rationale, design, and baseline characteristics of the Kaiser Permanente VACCination Improvement with Nudge-based CardiovAscular Targeted Engagement (KP-VACCINATE) MegatrialAnkeet S Bhatt, Alan S Go, Rishi V Parikh, et al.
Pageof 36